Image

Impact of Education Methods on HPV Knowledge and Screening Behavior

Impact of Education Methods on HPV Knowledge and Screening Behavior

Recruiting
30-65 years
Female
Phase N/A

Powered by AI

Overview

The aim of this study is to evaluate the effect of two different health education methods (one based on motivational interviewing) on women's HPV knowledge, cervical cancer health beliefs, and screening behaviors in women aged 30-65. A total of 96 healthy women who are registered at the Incirli Family Health Center in Ankara, meet the inclusion criteria, and volunteer to participate will be randomly assigned to three groups (32 participants per group).

The control group will receive standard healthcare services. The first intervention group will receive three sessions of motivational interviewing-based health education on cervical cancer prevention through home visits, along with an informational brochure. The second intervention group will receive health education and a brochure, followed by a reminder session via phone. At the end of the study, participants in the control group will be offered the intervention of their choice.

Description

This study aims to evaluate the effect of two different health education methods-one based on motivational interviewing-on HPV knowledge, cervical cancer health beliefs, and screening behavior in women aged 30-65. A total of 96 healthy women, registered at the Incirli Family Health Center in Ankara, who meet the inclusion criteria and provide informed consent, will be randomly assigned into three groups of 32 participants each.

The control group will receive standard healthcare services. The first intervention group will receive three face-to-face educational sessions based on motivational interviewing principles on HPV and cervical cancer prevention through home visits, along with an informational brochure. These sessions will occur during Weeks 1, 2, and 3. A final follow-up session to administer FORM II will be held in Week 8.

The second intervention group will receive a single face-to-face educational session on HPV and cervical cancer prevention (Week 1), receive a brochure, and two follow-up reminder sessions via telephone in Weeks 2 and 3. FORM II will be administered in Week 8.

After the study period, participants in the control group will be offered the opportunity to choose and receive one of the two intervention methods. All participants will complete the HPV Knowledge Scale, the Cervical Cancer and Pap Smear Test Health Belief Model Scale, and a VAS for self-assessment.

Eligibility

Inclusion Criteria:

  • Being between 30 and 65 years of age
  • Being literate
  • Agreeing to participate in the study
  • Being female
  • Being married
  • Having no history of cervical cancer in first-degree relatives (mother/sister)
  • Not having undergone cervical cancer screening in the last five years
  • Not having been diagnosed with cancer

Exclusion Criteria:

  • Being pregnant or in the postpartum period
  • Having been diagnosed with any type of cancer
  • Having a hearing or speech impairment, or a mental disorder
  • Using medication due to psychotic treatments
  • Having undergone a hysterectomy
  • Having had cervical cancer screening within the last five years
  • Having received all three doses of the HPV vaccine

Study details
    Health Education
    Motivational Interviewing

NCT07017387

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.